OPKO Health: Fourth Quarter Financial Overview
Opko Health Reports Fourth Quarter Financial Results
Opko Health Inc., headquartered in Miami, announced on Thursday that it recorded a net loss of $31.3 million for the fourth quarter.
This translates to a loss of 4 cents per share for the quarter.
Despite the loss, the company's performance surpassed analysts' expectations. According to Zacks Investment Research, the consensus among five analysts was a projected loss of 7 cents per share.
Opko Health, which holds interests in both pharmaceutical and diagnostics sectors, generated $148.5 million in revenue during the quarter, exceeding the $138.1 million anticipated by analysts surveyed by Zacks.
For the full year, the company reported a total loss of $225.7 million, or 30 cents per share, with annual revenue reaching $606.9 million.
Looking ahead, Opko Health anticipates revenue between $125 million and $140 million for the first quarter ending in March.
The company also projects its revenue for the entire year to fall within the range of $530 million to $560 million.
This article was produced by Automated Insights using data provided by Zacks Investment Research.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ethereum Holder Retention Rebounds From a 4-Year Low
日股收市:日经225指数跌0.48%,Lasertec半导体跌超5%
ATT Global Joins 4AI to Revolutionize AI-Driven Advertising
Permian Resources: How a Cost-Efficient Producer Navigates a Downturn
